[Federal Register Volume 66, Number 166 (Monday, August 27, 2001)]
[Notices]
[Page 45055]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-21519]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting of the National Cancer Advisory Board.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    A portion of the meeting will be closed to the public in accordance 
with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), as 
amended. The grant applications and the discussions could disclose 
confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the grant applications, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Advisory Board, Ad Hoc 
Subcommittee on Communications.
    Dates: September 10-11, 2001.
    Open: 7 p.m.-8:30 p.m.
    Agenda: To discuss activities related to the Ad Hoc Subcommittee 
on Communications.
    Place: Bethesda Hyatt Regency Hotel, One Bethesda Metro Center, 
Bethesda, MD 20814, (301) 657-1234.
    Contact Person: Dr. Susan Sieber, Executive Secretary, Ad Hoc 
Subcommittee on Communications, National Cancer Institute, National 
Institutes of Health, 9000 Rockville Pike, Building 31, Room 11A48, 
Bethesda, MD 20892, (301) 496-5946.

    Name of Committee: National Cancer Advisory Board, Subcommittee 
on Cancer Centers.
    Date: September 10, 2001.
    Open: 7 p.m.-8:30 p.m.
    Agenda: To discuss activities related to the Subcommittee on 
Cancer Centers.
    Place: Bethesda Hyatt Regency Hotel, One Bethesda Metro Center, 
Bethesda, MD 20814, (301) 657-1234.
    Contact Person: Dr. Brian Kimes, Executive Secretary, 
Subcommittee on Cancer Centers, National Cancer Institute, National 
Institutes of Health, 6116 Executive Blvd., Suite 700, Bethesda, MD 
20892, (301) 496-8537.

    Name of Committee: National Cancer Advisory Board.
    Date: September 11, 2001.
    Open: 8:30 a.m. to 12:15 p.m.
    Agenda: Program reports and presentations; Business of the 
Board.
    Place: National Cancer Institute, 9000 Rockville Pike, Building 
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.

    Name of Committee: National Cancer Advisory Board, Subcommittee 
on Clinical Investigations.
    Open: 12:25 p.m. to 1:30 p.m.
    Agenda: To discuss activities related to the Subcommittee on 
Clinical Investigations.
    Place: National Cancer Institute, 9000 Rockville Pike, Building 
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
    Contact Person: Dr. Ellen Feigal, Executive Secretary, 
Subcommittee on Clinical Investigations, National Cancer Institute, 
National Institutes of Health, 9000 Rockville Pike, Building 31, 
Room 3A44, Bethesda, MD 20892, (301) 496-6711.

    Name of Committee: National Cancer Advisory Board.
    Open: September 11, 2001, 1:30 p.m. to 3:50 p.m.
    Agenda: Program reports and presentations; Business of the 
Board.
    Place: National Cancer Institute, 9000 Rockville Pike, Building 
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.

    Name of Committee: National Cancer Advisory Board.
    Closed: September 11, 2001, 4:10 p.m. to Adjournment.
    Agenda: Review of grant applications; Discussion of confidential 
personnel issues.
    Place: National Cancer Institute, 9000 Rockville Pike, Building 
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
    Contact Person: Dr. Marvin R. Kalt, Executive Secretary, 
National Cancer Institute, National Institutes of Health, 6116 
Executive Boulevard, 8th Floor, Room 8001, Bethesda, MD 20892-8327, 
(301) 496-5147.
    This meeting is being published less than 15 days prior to the 
meeting due to scheduling conflicts. Any interested person may file 
written comments with the committee by forwarding the statement to 
the Contact Person listed on this notice. The statement should 
include the name, address, telephone number and when applicable, the 
business or professional affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: deainfo.nci.nih.gov/advisory/ncab.htm, where an agenda and any 
additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS).

    Dated: August 17, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-21519 Filed 8-24-01; 8:45 am]
BILLING CODE 4140-01-M